AU Stock MarketDetailed Quotes

IMR Imricor Medical Systems Inc

Watchlist
  • 0.525
  • 0.0000.00%
20min DelayTrading Jul 2 10:17 AET
106.51MMarket Cap-2638P/E (Static)

Imricor Medical Systems Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
Operating cash flow (direct method)
Cash income from operating activities
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
-6.63M
Other cash income from operating activities
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
---6.63M
Cash paid
Operating cash flow
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
---6.63M
Investing cash flow
Cash flow from continuing investing activities
65.34%-82.78K
65.65%-238.86K
10.17%-695.31K
-46.23%-774.03K
-529.34K
Net PPE purchase and sale
65.34%-82.78K
61.83%-238.86K
15.65%-625.75K
-103.39%-741.89K
---364.76K
Net investment purchase and sale
----
----
-116.39%-69.56K
---32.15K
----
Net other investing changes
----
----
----
----
---164.58K
Cash from discontinued investing activities
Investing cash flow
65.34%-82.78K
65.65%-238.86K
10.17%-695.31K
-46.23%-774.03K
---529.34K
Financing cash flow
Cash flow from continuing financing activities
108.29%8.21M
-65.96%3.94M
-64.92%11.59M
215.98%33.02M
10.45M
Net issuance payments of debt
10,601.99%2.62M
---24.97K
----
----
--3.45M
Net common stock issuance
33.99%5.76M
-64.66%4.3M
-63.58%12.17M
362.54%33.41M
--7.22M
Net other financing activities
48.44%-171.25K
42.86%-332.16K
-52.00%-581.3K
-76.24%-382.44K
---217.01K
Cash from discontinued financing activities
Financing cash flow
108.29%8.21M
-65.96%3.94M
-64.92%11.59M
215.98%33.02M
--10.45M
Net cash flow
Beginning cash position
-69.28%5.69M
-26.35%18.52M
397.93%25.14M
217.87%5.05M
--1.59M
Current changes in cash
62.15%-4.85M
-94.10%-12.81M
-132.95%-6.6M
507.75%20.02M
--3.29M
Effect of exchange rate changes
57.29%-9.71K
12.71%-22.74K
-136.74%-26.06K
-57.38%70.93K
--166.4K
End cash Position
-85.38%831.52K
-69.28%5.69M
-26.35%18.52M
397.93%25.14M
--5.05M
Free cash from
22.02%-13.06M
7.54%-16.75M
-39.64%-18.11M
-85.51%-12.97M
---6.99M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019
Operating cash flow (direct method)
Cash income from operating activities 21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M-6.63M
Other cash income from operating activities 21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M---6.63M
Cash paid
Operating cash flow 21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M---6.63M
Investing cash flow
Cash flow from continuing investing activities 65.34%-82.78K65.65%-238.86K10.17%-695.31K-46.23%-774.03K-529.34K
Net PPE purchase and sale 65.34%-82.78K61.83%-238.86K15.65%-625.75K-103.39%-741.89K---364.76K
Net investment purchase and sale ---------116.39%-69.56K---32.15K----
Net other investing changes -------------------164.58K
Cash from discontinued investing activities
Investing cash flow 65.34%-82.78K65.65%-238.86K10.17%-695.31K-46.23%-774.03K---529.34K
Financing cash flow
Cash flow from continuing financing activities 108.29%8.21M-65.96%3.94M-64.92%11.59M215.98%33.02M10.45M
Net issuance payments of debt 10,601.99%2.62M---24.97K----------3.45M
Net common stock issuance 33.99%5.76M-64.66%4.3M-63.58%12.17M362.54%33.41M--7.22M
Net other financing activities 48.44%-171.25K42.86%-332.16K-52.00%-581.3K-76.24%-382.44K---217.01K
Cash from discontinued financing activities
Financing cash flow 108.29%8.21M-65.96%3.94M-64.92%11.59M215.98%33.02M--10.45M
Net cash flow
Beginning cash position -69.28%5.69M-26.35%18.52M397.93%25.14M217.87%5.05M--1.59M
Current changes in cash 62.15%-4.85M-94.10%-12.81M-132.95%-6.6M507.75%20.02M--3.29M
Effect of exchange rate changes 57.29%-9.71K12.71%-22.74K-136.74%-26.06K-57.38%70.93K--166.4K
End cash Position -85.38%831.52K-69.28%5.69M-26.35%18.52M397.93%25.14M--5.05M
Free cash from 22.02%-13.06M7.54%-16.75M-39.64%-18.11M-85.51%-12.97M---6.99M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg